Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Result of AGM

26 Apr 2018 09:16

RNS Number : 2114M
Croda International PLC
26 April 2018
 

Croda International Plc - Annual General Meeting

 

The ninety-third Annual General Meeting of Croda International Plc (the "Company") was held at the Pavilions of Harrogate, Great Yorkshire Showground, North Yorkshire HG2 8QZ on Wednesday 25 April 2018.

 

All of the resolutions were voted upon by poll and were passed by shareholders. The total number of ordinary shares in issue: 131,643,021 (excluding shares held in treasury).

 

The results of the poll for each resolution are as follows:

 

 

Resolution

Votes For

Against

Withheld

No of shares

% of shares voted

No of shares

% of shares voted

 

No of shares

1. To receive the financial statements of the Company and the Group and the reports of the directors and auditors for the year ended 31 December 2017

90,221,483

99.65

313,434

0.35

577,974

2. To approve the Directors' Remuneration Report for the year ended 31 December 2017, in accordance with s439 of the Companies Act 2006

83,007,615

91.28

7,929,552

8.72

175,048

3. To declare a final dividend of 46.0 pence per ordinary share

90,328,398

99.95

44,488

0.05

740,005

4. To re-elect A M Ferguson as a director

87,787,600

96.53

3,156,628

3.47

168,465

5. To re-elect S E Foots as a director

88,283,418

97.07

2,662,212

2.93

167,063

6. To re-elect A M Frew as a director

88,059,479

96.83

2,881,108

3.17

172,105

7. To re-elect H L Ganczakowski as a director

89,634,712

98.60

1,274,186

1.40

206,795

8. To re-elect K Layden as a director

85,271,380

93.78

5,658,048

6.22

183,264

9. To re-elect J K Maiden as a director

87,670,123

96.40

3,275,766

3.60

167,077

10. To re-elect S G Williams as a director

88,918,516

97.77

2,024,168

2.23

170,009

11. To appoint KPMG LLP as auditors of the Company

90,827,305

99.87

117,656

0.13

167,930

12. To authorise the Audit Committee to determine the auditors' remuneration

90,872,329

99.92

70,434

0.08

169,073

13. Political donations

89,221,491

98.59

1,273,451

1.41

617,949

14. To authorise the directors to allot relevant securities up to two thirds of its issued share capital

80,741,977

88.78

10,203,393

11.22

166,466

15. To authorise the directors to allot equity securities without pre-emptive rights up to an aggregate nominal amount of £680,427

90,812,083

99.91

83,886

0.09

216,922

16. To authorise the directors to allot equity securities without pre-emptive rights up to an additional aggregate nominal amount of £680,427

89,486,018

98.45

1,408,397

1.55

217,420

17. To authorise market purchase of own shares up to a maximum of 13,139,279 ordinary shares

90,251,476

99.29

649,079

0.71

212,335

18. That a general meeting (other than an annual general meeting) may be called on not less than 14 clear days' notice

83,016,483

91.72

7,495,907

8.28

600,501

 

 

Resolutions 1 to 14 (inclusive) were passed as ordinary resolutions and resolutions 15 to 18 (inclusive) were passed as special resolutions. The full text of the resolutions is set out in the Notice of Annual General Meeting, a copy of which is on the Company's website (investor centre) and has also been made available for inspection through the National Storage Mechanism which can be found at http://www.morningstar.co.uk/uk/NSM.

 

 

 

Tom Brophy

Group General Counsel & Company Secretary

 

26 April 2018

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGFKADDFBKKNQB
Date   Source Headline
12th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSThird Quarter Trading Update
6th Oct 20234:12 pmRNSDirector/PDMR Shareholding
5th Oct 20238:53 amRNSHolding(s) in Company
3rd Oct 20234:03 pmRNSDirector/PDMR Shareholding
27th Sep 20235:17 pmRNSDirector/PDMR Shareholding
26th Sep 202311:38 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirectorate Change
15th Sep 202311:51 amRNSDirector/PDMR Shareholding
12th Sep 20234:01 pmRNSDirector/PDMR Shareholding
12th Sep 20238:56 amRNSDirector/PDMR Shareholding
11th Aug 20232:26 pmRNSDirector/PDMR Shareholding
1st Aug 20237:13 amRNSDirector Declaration
25th Jul 20237:00 amRNSResults for the six months ended 30 June 2023
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
4th Jul 20238:02 amRNSCroda completes acquisition of Solus Biotech
26th Jun 202310:46 amRNSHolding(s) in Company
13th Jun 20233:55 pmRNSDirector/PDMR Shareholding
12th Jun 20232:06 pmRNSDirector/PDMR Shareholding
9th Jun 20237:00 amRNSTrading update
31st May 20232:47 pmRNSDirector/PDMR Shareholding
26th May 20233:51 pmRNSDirector/PDMR Shareholding
11th May 20234:05 pmRNSDirector/PDMR Shareholding
3rd May 20233:08 pmRNSDirector/PDMR Shareholding
3rd May 20233:00 pmRNSDirector/PDMR Shareholding
2nd May 20232:30 pmRNSDirector/PDMR Shareholding
27th Apr 20239:18 amRNSResult of AGM
24th Apr 20234:49 pmRNSDirector/PDMR Shareholding
12th Apr 20232:00 pmRNSDirector/PDMR Shareholding
28th Mar 20233:51 pmRNSDirector/PDMR Shareholding
28th Mar 20233:50 pmRNSDirector/PDMR Shareholding
28th Mar 20233:47 pmRNSDirector/PDMR Shareholding
28th Mar 20233:46 pmRNSDirector/PDMR Shareholding
28th Mar 20233:44 pmRNSDirector/PDMR Shareholding
28th Mar 20233:42 pmRNSDirector/PDMR Shareholding
28th Mar 20233:41 pmRNSDirector/PDMR Shareholding
28th Mar 20233:41 pmRNSDirector/PDMR Shareholding
27th Mar 20233:52 pmRNSDirector/PDMR Shareholding
27th Mar 20233:48 pmRNSDirector/PDMR Shareholding
24th Mar 202310:57 amRNSDirector/PDMR Shareholding
24th Mar 202310:31 amRNSDirectorate Change
17th Mar 20235:12 pmRNSAnnual Financial Report
17th Mar 20232:30 pmRNSDirector/PDMR Shareholding
17th Mar 202310:53 amRNSDirector/PDMR Shareholding
13th Mar 20232:02 pmRNSDirector/PDMR Shareholding
3rd Mar 202311:57 amRNSDirector/PDMR Shareholding
28th Feb 20239:21 amRNSDirectorate Change
28th Feb 20237:00 amRNSResults for the year ended 31 December 2022
13th Feb 20232:14 pmRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSAcquisition of Solus Biotech

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.